Drug Profile
Isoharringtonine
Latest Information Update: 28 May 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Alkaloids; Antineoplastics
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 May 2001 No-Development-Reported for Cancer in China (Unknown route)
- 26 Nov 1998 New profile
- 26 Nov 1998 Preclinical development for Cancer in China (Unknown route)